PCIエキスパートになるための28カ条

出版社： メジカルビュー社
著者：
発行日： 2021-04-01
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784758319737
電子書籍版： 2021-04-01 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

5,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,500 円(税込)

購入する

商品紹介

経皮的冠動脈インターベンション（PCI）についての基礎はひととおり押さえているが，独り立ちにはまだ不安があるといった若手医師に向けた虎の巻。これを読めば，エキスパート達が「何を理解し」「何を考え」「何を身につけ」PCIを行っているのかがわかる。
手技の上達，さらなるレベルアップのための極意を凝縮した必携の一冊！

目次

  • 第1条　PCI 前の虚血評価により，PCI が必須かどうかを見極めるべし
    第2条　冠動脈造影の心得：病変評価の重要性を識るべし
    第3条　患者リスク評価の心得：術前評価の重要性を識るべし
    第4条　穿刺のテクニックを身につけるべし
    第5条　アプローチ部位とガイディングカテーテル選択：バックアップを考察すべし
    第6条　ガイドワイヤーを使いこなすべし
    第7条　場面に応じてバルーンを選択すべし
    第8条　ステントの種類と構造を理解すべし
    第9条　マイクロカテーテルの使い分けを身につけるべし
    第10条　薬剤コーテッドバルーン（DCB）の適応と活かし方を押さえるべし
    第11条　IVUS ガイド PCI：エキスパートの視点を学ぶべし
    第12条　OCT/OFDI ガイド PCI：エキスパートの視点を学ぶべし
    第13条　急性冠症候群（ACS）に立ち向かうときの心構えを身につけよ
    第14条　石灰化病変を正しく評価し治療戦略を考えるべし
    第15条　分岐部病変を正しく評価し治療戦略を考えるべし
    第16条　CTO 病変の評価とantegrade approach の手法を会得せよ
    第17条　Retrograde approach の望ましい症例を見極めよ
    第18条　糖尿病症例へのPCI：エキスパートの思考を学ぶべし
    第19条　高齢者へのPCI：エキスパートのエンドポイント設定を学ぶべし
    第20条　BRS の適応，適切な留置術，術後管理：エキスパートの思考を学ぶべし
    第21条　ステント血栓症の分類：成因を理解し，正しく対策せよ
    第22条　高出血リスク（HBR）とわかったときの対応：エキスパートに学ぶべし
    第23条　冠動脈解離を正しく評価し，適切にマネージメントすべし（特発性含む）
    第24条　メカニズムに応じてステント再狭窄に備えよ　　 舩津篤史，中村　茂
    第25条　事前に備えよ！　心タンポナーデ，slow fl ow，コレステロール塞栓症
    第26条　造影剤腎症を回避せよ：エキスパートのノウハウはこうだ！
    第27条　術前後の抗血栓療法エッセンス：これで君もエキスパートだ！
    第28条　虚血関連のエビデンスを押さえるべし（ISCHEMIA 試験，ORBITA 試験）

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1条 PCI前の虚血評価により, PCIが必須かどうかを見極めるべし

P.15 掲載の参考文献
1) Maron DJ, Hochman JS, Reynolds HR, et al : Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382 : 1395-1407, 2020.
 
2) Pijls NHJ, van Schaardenburgh P, Manoharanet G, et al : Percutaneous coronary intervention of functional nonsignificant stenosis : 5 year follow up of the DEFER study. J Am Coll Cardiol 49 : 2105-2111, 2007.
 
3) Zimmermann FM, Ferrara A, Johnson NP, et al : Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis : 15-year followup of the DEFER trial. Eur Heart J 36 : 3182-3188, 2015.
 
4) Tonino PA, De Bruyne B, Pijls NHJ, et al : FAME Study Investigators : Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 : 213-224, 2009.
 
5) Tonino PA, Fearon WF, De Bruyne B, et al : Angiographic versus functional severity of coronary artery stenoses in the FAME Study. Fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 55 : 2816-2821, 2010.
PubMed
6) De Bruyne B, Fearon WF, Pijls NHJ, et al : FAME 2 Trial Investigators : Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371 : 1208-1217, 2014.
 

第3条 患者リスク評価の心得 : 術前評価の重要性を識るべし

P.26 掲載の参考文献
1) 日本循環器学会 : 2020年 JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法 (班長, 木村一雄, 中村正人). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf (2021年1月閲覧)
 
2) Watanabe H, Domei T, Morimoto T, et al : Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI : The STOPDAPT-2 randomized clinical trial. JAMA 321 : 2414-2427, 2019.
 
3) Ishida M, Takahashi F, Goto I, et al : Clinical outcomes of patients treated using very short duration dual antiplatelet therapy after implantation of biodegradable-polymer drugeluting stents : rationale and design of a prospective multicenter REIWA registry. Cardiovasc Interv Ther 35 : 398-404, 2020.
 
4) Cannon CP, Bhatt DL, Oldgren J, et al : Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377 : 1513-1524, 2017.
PubMed
5) Gibson CM, Mehran R, Bode C, et al : Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375 : 2423-2434, 2016.
PubMed
6) 日本動脈硬化学会 : 動脈硬化性疾患予防ガイドライン 2017年版. 日本動脈硬化学会, 2017.
Medical*Online
7) Tonino PA, De Bruyne B, Pijls NH, et al : Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 : 213-224, 2009.
PubMed
8) Zimmermann FM, Ferrara A, Johnson NP, et al : Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis : 15-year follow-up of the DEFER trial. Eur Heart J 36 : 3182-3188, 2015.
PubMed
9) Weintraub WS, Spertus JA, Kolm P, et al : Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359 : 677-687, 2008.
PubMed
10) Maron DJ, Hochman JS, Reynolds HR, et al : Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382 : 1395-1407, 2020.
 

第4条 穿刺のテクニックを身につけるべし

P.32 掲載の参考文献
1) Garrett PD, Eckart RE, Bauch TD, et al : Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation. Catheter Cardiovasc Interv 65 : 205-207, 2005.
PubMed
2) Tiroch KA, Matheny ME, Resnic FS : Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization. Am Heart J 159 : 125-130, 2010.
PubMed
3) Savolainen H, Baumgartner I, Schmidli J, et al : Femoral pseudoaneurysms requiring surgical treatment. Trauma Mon 16 : 194-197, 2012.
PubMed
4) Slattery MM, Goh GS, Power S, et al : Comparison of ultrasound-guided and fluoroscopy-assisted antegrade common femoral artery puncture techniques. Cardiovasc Intervent Radiol 38 : 579-582, 2015.
PubMed
5) 笠井智司, ほか : 達人が教える! PCI・カテーテル室のピンチからの脱出法 119 (村松俊哉, 編). 南江堂, 東京, 2014, p65.
 
6) Seto AH, Roberts JS, Abu-Fadel MS, et al : Real-time ultrasound guidance facilitates transradial access : RAUST (Radial Artery access with Ultrasound Trial). JACC Cardiovasc Interv 8 : 283-291, 2015.
PubMed
7) Kiemeneij F : Left distal transradial access in the anatomical snuffbox for coronary angiography (1dTRA) and interventions (1dTRI). EuroIntervention 13 : 851-857, 2017.
PubMed
8) [Article in Russian] Kaledin AL, Kochanov IN, Seletskii SS, et al : [Peculiarities of arterial access in endovascular surgery in elderly patients]. Adv Gerontol 27 : 115-119, 2014.
PubMed
9) Fergusson DJ, Kamada RO : Percutaneous entry of the brachial artery for left heart catheterization using a sheath. Cathet Cardiovasc Diagn 7 : 111-114, 1981.
PubMed
10) Kedev S, Zafirovska B, Dharma S, Petkoska D : Safety and feasibility of transulnar catheterization when ipsilateral radial access is not available. Catheter Cardiovasc Interv 83 : E51-E60, 2014.
 
11) Kwan TW, Ratcliffe JA, Chaudhry M, et al : Transulnar catheterization in patients with ipsilateral radial artery occlusion. Catheter Cardiovasc Interv 82 : E849-E855, 2013.
PubMed
12) Troianos CA, Hartman GS, Glas KE, et al : Councils on Intraoperative Echocardiography and Vascular Ultrasound of the American Society of Echocardiography : Guidelines for performing ultrasound guided vascular cannulation : recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 24 : 1291-1318, 2011.
 

第8条 ステントの種類と構造を理解すべし

P.56 掲載の参考文献
1) Nakazawa G : Stent thrombosis of drug eluting stent : pathological perspective. J Cardiol 58 : 84-91, 2011.
PubMed
2) Nakazawa G, Otsuka F, Nakano M et al : The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 57 : 1314-1322, 2011.
 
3) Torii S, Jinnouchi H, Sakamoto A et al : Drug-eluting coronary stents : insights from preclinical and pathology studies. Nat Rev Cardiol 17 : 37-51, 2020.
PubMed
4) Kolandaivelu K, Swaminathan R, Gibson WJ et al : Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123 : 1400-1409, 2011.
PubMed

第10条 薬剤コーテッドバルーン ( DCB ) の適応と活かし方を押さえるべし

P.67 掲載の参考文献
1) Habara S, Iwabuchi M, Inoue N, et al : A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 166 : 527-533, 2013.
 
2) Habara S, Kadota K, Shimada T, et al : Late restenosis after Paclitaxel-coated balloon angioplasty occurs in patients with drug-eluting stent restenosis. J Am Coll Cardiol 66 : 14-22, 2015.
PubMed
3) Miura K, Tada T, Habara S, et al : Optical coherence tomography predictors for recurrent restenosis after Paclitaxel-coated balloon angioplasty for drug-eluting stent restenosis. Circ J 82 : 2820-2828, 2018.
PubMed
4) Cortese B, Di Palma G, Guimaraes MG, et al : Drug-coated balloon versus drug-eluting stent for small coronary vessel disease : PICCOLETO II randomized clinical trial. JACC Cardiovasc Interv 13 : 2840-2849, 2020.
PubMed
5) Worthley S, Hendriks R, Worthley M, et al : Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations : 12-month results of the multicenter BIOLUX-I study. Cardiovasc Revasc Med 16 : 413-417, 2015.
PubMed
6) Kitani S, Igarashi Y, Tsuchikane E, et al : Efficacy of drugcoated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry). Catheter Cardiovasc Interv, 2020 Aug 10. Online ahead of print.
 

第11条 IVUSガイドPCI : エキスパートの視点を学ぶべし

P.73 掲載の参考文献
1) Zhang Y, Farooq V, Garcia-Garcia HM, et al : Comparison of intravascular ultrasound versus angiography-guided drugeluting stent implantation : a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention 8 : 855-865, 2012.
 
2) Klersy C, Ferlini M, Raisaro A, et al : Use of IVUS guided coronary stenting with drug eluting stent : a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int J Cardiol 170 : 54-63, 2013.
PubMed
3) Jang JS, Song YJ, Kang W, et al : Intravascular ultrasoundguided implantation of drug-eluting stents to improve outcome : a meta-analysis. JACC Cardiovasc Interv 7 : 233-243, 2014.
 
4) Ahn JM, Kang SJ, Yoon SH, et al : Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol 113 : 1338-1347.
PubMed
5) Steinvil A, Zhang YJ, Lee SY, et al : Intravascular ultrasoundguided drug-eluting stent implantation : an updated meta-analysis of randomized control trials and observational studies. Int J Cardiol 216 : 133-139.
 
6) Elgendy IY, Mahmoud AN, Elgendy A.Y, et al : Outcomes with intravascular ultrasound-guided stent implantation : a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc Interv 9 : e003700,2016.
PubMed
7) Shin D.H, Hong S.J, Mintz G.S, et al : Effects of intravascular ultrasound-guided versus angiography-guided new-generation drug-eluting stent implantation : meta-analysis with individual patient-level data from 2,345 randomized patients. JACC Cardiovasc Interv 9 : 2232-2239, 2016.
PubMed
8) Kubo T, Shinke T, Okamura T, et al : Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial) : one-year angiographic and clinical results. Eur. Heart J 38, 3139-3147, 2017.
PubMed

第12条 OCT / OFDIガイドPCI : エキスパートの視点を学ぶべし

P.78 掲載の参考文献
1) Kubo T, Shinke T, Okamura T et al : Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial) : one-year angiographic and clinical results. Eur Heart J 38 : 3139-3147. 2017.
PubMed
2) Kubo T, Akasaka T, Shite J et al : OCT compared with IVUS in a coronary lesion assessment : the OPUS-CLASS study. JACC Cardiovasc Imaging 6 : 1095-1104, 2013.
 
3) Ali ZA, Maehara A, Genereux P et al : Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III : OPTIMIZE PCI) : a randomised controlled trial. Lancet 388 : 2618-2628, 2016.
PubMed
4) Kume T, Okura H, Miyamoto Y et al : Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation-preliminary observation. Circ J 76 : 698-703, 2012.
PubMed
5) Kobayashi Y, Okura H, Kume T et al : Impact of target lesion coronary calcification on stent expansion. Circ J 78 : 2209-2214, 2014.
PubMed
6) Maejima N, Hibi K, Saka K et al : Relationship Between Thickness of Calcium on Optical Coherence Tomography and Crack Formation After Balloon Dilatation in Calcified Plaque Requiring Rotational Atherectomy. Circ J 80 : 1413-1419, 2016.
PubMed

第13条 急性冠症候群 ( ACS ) に立ち向かうときの心構えを身につけよ

P.83 掲載の参考文献
1) 日本循環器学会 : 急性冠症候群ガイドライン (2018年改訂版) (班長, 木村一雄). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_kimura.pdf (2021年1月閲覧)
 
2) Shiomi H, Nakagawa Y, Morimoto T, et al : Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention : observational study. BMJ 344 : e3257, 2012.
PubMed
3) 日本蘇生協議会, 日本救急医療財団監修. JRC蘇生ガイドライン 2010. へるす出版 2011.
 

第15条 分岐部病変を正しく評価し治療戦略を考えるべし

P.95 掲載の参考文献
1) Medina A, Suarez de Lezo J, Pan M : A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59 : 183, 2006.
 
2) Koo BK, Kang HJ, Youn TJ, et al : J Am Coll Cardiol 46 : 633-637, 2005.
PubMed

第16条 CTO病変の評価とantegrade approachの手法を会得せよ

P.105 掲載の参考文献
1) Habara M, Tsuchikane E, Muramatsu T ; Retrograde Summit Investigators, et al : Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry. Catheter Cardiovasc Interv 87 : 1027-1035. 2016.
PubMed
2) Morino Y, Abe M, Morimoto T, J-CTO Registry Investigators, et al : Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes : the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4 : 213-221, 2011.
 
3) Harding SA, Wu EB, Lo S, et al : A New Algorithm for Crossing Chronic Total Occlusions From the Asia Pacific Chronic Total Occlusion Club. JACC Cardiovasc Interv 10 : 2135-2143. 2017.
 
4) Sumitsuji S, Inoue K, Ochiai M, et al : Fundamental wire technique and current standard strategy of percutaneous intervention for chronic total occlusion with histopathological insights. JACC Cardiovasc Interv4 : 941-951, 2011.
PubMed

第18条 糖尿病症例へのPCI : エキスパートの思考を学ぶべし

P.116 掲載の参考文献
1) Tada T, Kimura T, Morimoto T, et al : Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol 107 : 1155-1162, 2011.
 
2) Neumann FJ, Neumann FJ, Sousa-Uva M, et al : 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J, 2018. doi : 10.1093/eurheartj/ehy394.
 
3) Farkouh ME, Domanski M, Dangas GD, et al : Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study). J Am Coll Cardiol, 2018. doi : 10.1016/j.jacc.2018.11.001.
 
4) Guandalini GS, Bangalore S. The Potential Effects of New Stent Platforms for Coronary Revascularization in Patients With Diabetes. Can J Cardiol 34 : 653-664, 2018.
PubMed
5) Davies MJ, D'Alessio DA, Fradkin J, et al : Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41 : 2669-2701, 2018.
 

第19条 高齢者へのPCI : エキスパートのエンドポイント設定を学ぶべし

P.123 掲載の参考文献
1) Uemura S, Okamoto H, Nakai M, et al : Primary percutaneous coronary intervention in elderly patients with acute myocardial infarction -An analysis from a Japanese nationwide claim-based database. Circ J 83 : 1229-1238, 2019.
PubMed
2) Maron DJ, Hochman JS, Reynolds HR, et al : Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382 : 1395-1407, 2020.
 
3) Shin JS, Tahk SJ, Yang HM, et al : Impact of female gender on bleeding complications after transradial coronary intervention (from the Korean Transradial Coronary Intervention registry). Am J Cardiol 113 : 2002-2006, 2014.
PubMed
4) Brener MI, Bush A, Miller JM, et al : Hasan RK. Influence of Radial Versus Femoral Access Site on Coronary Angiography and Intervention Outcomes : A Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv 90 : 1093-1104, 2017.
PubMed
5) Tammam K, Ikari Y, Yoshimachi F et al : Impact of transradial coronary intervention on bleeding complications in octogenarians. Cardiovasc Interv and Ther 32 : 18-23, 2017.
PubMed
6) Gellen B, Lesault PF, Canoui-Poitrine F, et al : Feasibility limits of transradial primary percutaneous coronary intervention in acute myocardial infarction in the real life (TRAP-AMI). Int J Cardiol 168 : 1056-1061, 2013.
PubMed
7) Tegn N, Abdelnoor M, Aaberge L, et al : Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study) : an open-label randomised controlled trial. Lancet 387 : 1057-1065, 2016.
 

第20条 BRSの適応, 適切な留置術, 術後管理 : エキスパートの思考を学ぶべし

P.129 掲載の参考文献
1) Ali ZA, Gao R, Kimura T, et al : Three-Year Outcomes With the Absorb Bioresorbable Scaffold : Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials. Circulation 137 : 464-479, 2018.
PubMed
2) Wykrzykowska JJ, Kraak RP, Hofma SH, et al : Bioresorbable Scaffolds versus Metallic Stents in Routine PCI. N Engl J Med 376 : 2319-2328, 2017.
PubMed
3) Karanasos A, Van Mieghem N, van Ditzhuijzen N, et al : Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis : single-center experience. Circ Cardiovasc Interv 8, 2015.
PubMed

第21条 ステント血栓症の分類 : 成因を理解し, 正しく対策せよ

P.136 掲載の参考文献
1) Palmerini T, Biondi-Zoccai G, Della Riva D, et al : Stent thrombosis with drug-eluting and bare-metal stents : evidence from a comprehensive network meta-analysis. Lancet 379 : 1393-1402, 2012.
PubMed
2) Holmes DR Jr, Kereiakes DJ, Garg S, et al : Stent thrombosis. J Am Coll Cardiol 56 : 1357-1365, 2010.
PubMed
3) 日本循環器学会 : 2020年JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法 (班長, 木村一雄, 中村正人). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf (2021年1月閲覧)
 
4) Mehran R, Baber U, Steg PG, et al : Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS) : 2 year results from a prospective observational study. Lancet 382 : 1714-1722, 2013.
PubMed
5) Nakamura M, Isshiki T, Kimura T, et al : Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period : post-hoc analysis of the randomized PRASFIT-ACS study. Int J Cardiol 182 : 541-548, 2015.
PubMed
6) Imai M, Kadota K, Goto T, et al : Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation 123 : 2382-2391, 2011.
PubMed

第22条 高出血リスク ( HBR ) とわかったときの対応 : エキスパートに学ぶべし

P.142 掲載の参考文献
1) Nakamura M, Iijima R : Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention : Start with what is right rather than what is acceptable. J Cardiol, 2020. Online ahead of print.
 
2) 日本循環器学会 : 2020年JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法 (班長, 木村一雄, 中村正人). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf (2021年1月閲覧)
 
3) Nakamura M, Kadota K, Takahashi A, et al : Relationship between platelet reactivity and ischemic and bleeding events after percutaneous coronary intervention in East Asian patients : 1-year results of the PENDULUM registry. J Am Heart Assoc 9 : e015439, 2020.
PubMed
4) Watanabe H, Domei T, Morimoto T, et al : Effect of 1-month dual antiplatelet therapy fFollowed by Clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI : The STOPDAPT-2 randomized clinical trial. JAMA 321 : 2414-2427, 2019.
 
5) Nakamura M, Morino Y, Kakuta T, et al : Monotherapy with Prasugrel after dual-antiplatelet therapy for Japanese percutaneous coronary intervention patients with high bleeding risk-a prospective cohort study (PENDULUM mono study). Circ J 85 : 27-36, 2020.
 

第23条 冠動脈解離を正しく評価し, 適切にマネージメントすべし ( 特発性含む )

P.147 掲載の参考文献
1) Saw J : Spontaneous coronary artery dissection. Can J Cardiol 29 : 1027-1033, 2013.
PubMed
2) Vanzetto G, Berger-Coz E, Barone-Rochette G et al : Prevalence, therapeutic management and medium-term prognosis of spontaneous coronary artery dissection : results from a data base of 11,605 patients. Eur J Cardiothorac Surg 35 : 250-254, 2009.
 
3) Saw J : Coronary angiogram classification of spontaneous coronary artery dissection. Catheter Cardiovasc Interv 84 : 1115-1122, 2014.
PubMed
4) Nishiguchi T, Tanaka T, Taruya A, et al : Prognosis of spontaneous coronary artery dissection treated by percutaneous coronary intervention with optical coherence tomography. J Cardiol 70 : 524-529, 2017.
 
5) Alfonso F, Paulo M, Lennie V, et al : Spontaneous coronary artery dissection : long-term follow-up of a large series of patients prospectively managed with a "conservative" therapeutic strategy. JACC Cardiovasc Interv 5 : 1062-1070, 2012.
PubMed
6) Saw J, Ricci D, Starovoytov A, et al : Spontaneous coronary artery dissection : prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. JACC Cardiovasc Interv 6 : 44-52, 2013.
 
7) Nakashima T, Noguchi T, Haruta S, et al : Prognostic impact of spontaneous coronary artery dissection in young female patients with acute myocardial infarction : A report from the Angina Pectoris-Myocardial Infarction Multicenter Investigators in Japan. Int J Cardiol 207 : 341-348, 2016.
PubMed

第24条 メカニズムに応じてステント再狭窄に備えよ

P.156 掲載の参考文献
1) Habara S, Iwabuchi M, Inoue N, et al : A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with baremetal stent restenosis and drug-eluting stent restenosis. Am Heart J 166, 527-533, 2013.
 

第27条 術前後の抗血栓療法エッセンス : これで君もエキスパートだ！

P.175 掲載の参考文献
1) 日本循環器学会 : 2020年 JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法 (班長, 木村一雄, 中村正人). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf (2021年1月閲覧)
 
2) Natsuaki M, Morimoto T, Yamaji K, et al : Prediction of thrombotic and bleeding events after percutaneous coronary intervention : CREDO-Kyoto thrombotic and bleeding risk scores. J Am Heart Assoc 7 : e008708, 2018.
PubMed
3) Baber U, Mehran R, Giustino G, et al : Coronary thrombosis and major bleeding after PCI with drug-eluting stents : risk scores from PARIS. J Am Coll Cardiol 67 : 2224-2234, 2016.
 
4) Costa F, van Klaveren D, James S, et al : Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score : a pooled analysis of individual-patient datasets from clinical trials. Lancet 389 : 1025-1034, 2017.
 
5) Yeh RW, Secemsky E, Kereiakes DJ, et al : Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA 315 : 1735-1749, 2016.
PubMed
6) Urban P, Mehran R, Colleran R, et al : Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation 140 : 240-261, 2019.
PubMed
7) Cuisset T, Deharo P, Quilici J, et al : Benefit of switching dual antiplatelet therapy after acute coronary syndrome : the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. Eur Heart J 38 : 3070-3078, 2017.
PubMed
8) Vranckx P, Valgimigli M, Juni P, et al : Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent : a multicentre, open-label, randomised superiority trial. Lancet 392 : 940-949, 2018.
PubMed
9) Watanabe H, Domei T, Morimoto T, et al : Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI : The STOPDAPT-2 randomized clinical trial. JAMA 321 : 2414-2427, 2019.
 
10) Goto K, Nakai K, Shizuta S, et al : Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 114 : 70-78, 2014.
PubMed
11) Yasuda S, Kaikita K, Akao M, et al : Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med 381 : 1103-1113, 2019.
PubMed

第28条 虚血関連のエビデンスを押さえるべし ( ISCHEMIA試験, ORBITA試験 )

P.179 掲載の参考文献
1) Boden WE, O'Rourke RA, Teo KK, et al : Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 : 1503-1516, 2007.
PubMed
2) Shaw LJ, Berman DS, Maron DJ, et al : Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden : results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117 : 1283-1291, 2008.
 
3) Xaplanteris P, Fournier S, Pijls NHJ, et al : Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379 : 250-259, 2018.
PubMed
4) Maron DJ, Hochman JS, Reynolds HR, et al : Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382 : 1395-1407, 2020.
 
5) Spertus JA, Jones PG, Maron DJ, et al : Health-status outcomes with invasive or conservative care in coronary disease. N Engl J Med 382 : 1408-1419, 2020.
 
6) Al-Lamee R, Thompson D, Dehbi HM, et al : Percutaneous coronary intervention in stable angina (ORBITA) : a double-blind, randomised controlled trial. Lancet 391 : 31-40, 2018.
PubMed

書評

最近チェックした商品履歴

Loading...